2 sources checked · 2 source groups included · 1h ago
Still Watching
Trump administration will fund new research on controversial psychedelic drug ibogaine
The Seattle Times and Washington Examiner describe the same event in different terms.
1 Left0 Center1 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of November 12, 2026 at 5:25 PM, this is how Optics News reads the wording differences in this story.
What happenedFederal officials say there's new funding to study the medical potential of a powerful psychedelic.
The headline splitThe left frames it as "Trump administration will fund new research on controversial psychedelic drug ibogaine". The right frames it as "Trump administration fast-tracks ibogaine research for PTSD".
Match confidenceDeveloping. The source map is still developing. Keep watching for more sources to join.
Same-event confidenceDeveloping
Not enough sources yet to confirm this is the same specific event.
Framing confidenceHidden
Wording-gap score hidden — source map is too narrow to read confidently.
WHAT EACH SIDE EMPHASIZED
Left / center-leftTrump administration will fund new research on controversial psychedelic drug ibogaine
The Seattle Times · Center-left · News report
CenterNo matching source in this bucket yet.
Optics keeps watching for pickup.
Right / center-rightTrump administration fast-tracks ibogaine research for PTSD
Trump administration fast-tracks ibogaine research for PTSD
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other s...